The market has shown positive momentum, climbing 1.3% over the last week and 28% in the past year, with earnings expected to grow by 17% per annum in the coming years. For investors willing to explore beyond well-known companies, penny stocks—often smaller or newer firms—can offer unique opportunities that align with current market growth trends. Despite being an older term, penny stocks remain relevant for those seeking potential value and growth, as they can provide financial strength and stability often overlooked by larger entities.

We're going to check out a few of the best picks from our screener tool.

SunCar Technology Group (SDA)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: SunCar Technology Group Inc. operates through its subsidiaries to offer cloud and mobile app-based auto eInsurance, technology, and auto services in the People’s Republic of China, with a market cap of $68.96 million.

Operations: The company's revenue is primarily derived from its Auto Service segment at $223.10 million, followed by Auto eInsurance Service at $212.57 million, and Technology Service contributing $53.62 million.

Market Cap: $68.96M

SunCar Technology Group Inc. has shown significant revenue growth, reporting US$131.17 million for Q1 2026, up from US$102.6 million a year earlier, with a net income of US$0.832 million compared to a prior loss. The company maintains its full-year revenue guidance at US$600 million and recently secured a three-year contract valued at US$50 million with the Agricultural Bank of China for concierge chauffeur services, underscoring its strong market position in China’s banking sector. Despite past volatility and unprofitability challenges, SunCar's debt levels have improved and it holds sufficient cash runway for over three years.

Sera Prognostics (SERA)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Sera Prognostics, Inc. is a women's health company focused on discovering, developing, and commercializing blood-based biomarker tests and predictive analytic products in the United States, with a market cap of $84.19 million.

Operations: The company's revenue is generated from developing and commercializing its medical diagnostic products, totaling $0.057 million.

Market Cap: $84.19M

Sera Prognostics, Inc. is a pre-revenue company with a market cap of US$84.19 million, focusing on women's health diagnostics. Despite generating minimal revenue of US$0.014 million in Q1 2026, the company maintains a robust financial position with short-term assets of US$49.7 million exceeding liabilities and being debt-free. The company's stock has experienced high volatility but shows improved weekly stability over the past year. Sera recently filed for follow-on equity offerings worth US$40 million, potentially bolstering its cash runway beyond the current 1.5 years if free cash flow growth continues at historical rates.

Chegg (CHGG)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Chegg, Inc. offers a learning platform that equips businesses and lifelong learners with essential skills for success both in the United States and internationally, with a market cap of approximately $159 million.

Operations: The company's revenue is primarily generated from its Educational Services segment, specifically in Education & Training Services, amounting to $318.78 million.

Market Cap: $158.98M

Chegg, Inc., with a market cap of US$159 million, has faced challenges in maintaining profitability despite generating US$63.26 million in Q1 2026 revenue. The company is unprofitable and not expected to achieve profitability soon. However, Chegg's strategic focus on AI model training using its proprietary academic content positions it uniquely within the educational services sector. Recent product announcements highlight its potential to meet growing demand for high-quality STEM data sets in AI development. The company's cash position is strong, with short-term assets exceeding liabilities and more cash than total debt, providing some financial stability amidst ongoing volatility and restructuring efforts like a proposed reverse stock split.

Summing It All Up

• Click here to access our complete index of 336 US Penny Stocks.
• Interested In Other Possibilities? Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.